Testing a Prostate Cancer Risk Calculator for Primary Care Providers in Nigeria
Tests a prostate cancer risk calculator with primary care providers caring for Nigerian men.
Plain-language title generated from the registry record
Registry title: PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria
Key facts
- Where
- Zaria, NigeriaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for primary care providers at community-level hospitals, and adult men aged 40 to 79 who visit these providers, to test a prostate cancer risk calculator.
- Age
- Providers: not stated. Patients: men aged 40 to 79 years. The registry lists a minimum age of 18 years.
- Sex
- Male
- Earlier treatment
- Providers who give the supported risk assessment must have been trained to do it.
Read by machine on 13 November 2026.
Where in Nigeria
- Ahmadu Bello University Teaching HospitalZaria, NigeriaContact: Musliu Adetola TOLANI, MBBS PGCertPH ChM FWACS FMCSNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Ahmadu Bello University
- Trial code
- NCT07733440
- Record updated
- 29 July 2026
- Original description
This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population.Read full original descriptionShow less
Clinical Risk Calculator Validation and Implementation to Optimize Prostate Cancer Early Detection in Nigeria
This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population.
The main questions the validation study aims to answer are:
1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer? 2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer?
The main questions the intervention study aims to answer is:
Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement?
The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes
Inclusion: Training - Eligible primary care providers (for the training surveys) will be healthcare practitioners at community-level hospitals; Supported Risk Assessment; (i) Eligible key informants will be eligible primary care providers who were trained and implemented the supported risk assessment and the targeted population of patient participants who received the supported risk assessment; (ii) Eligible patient participants (for the collection of observation data) will be the target population of adult males 40 - 79 years accessing provider services.
Exclusion: -.